ARTICLE | Company News
Chiroscience, Knoll AG deal
March 11, 1996 8:00 AM UTC
The companies will develop and market isomer versions of the cardiovascular drug verapamil. The program is expected to enter the clinic by the end of 1996. CRO will receive an up-front payment from Kn...